| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/23/2011 | US20110150937 Extended release compositions comprising tolterodine |
| 06/23/2011 | US20110150936 Anti-tumoral cells |
| 06/23/2011 | US20110150930 Recombinant viral-based malaria vaccines |
| 06/23/2011 | US20110150917 Small Cationic Antimicrobial Peptides |
| 06/23/2011 | US20110150910 Methods of inducing an immune response |
| 06/23/2011 | US20110150906 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer |
| 06/23/2011 | US20110150902 Treating cancer |
| 06/23/2011 | US20110150900 Regulation of fatty acid transporters |
| 06/23/2011 | US20110150897 Influenza targets |
| 06/23/2011 | US20110150894 Methods of modulating angiogenesis via trpv4 |
| 06/23/2011 | US20110150890 Use of cgrp antagonist compounds for treatment of psoriasis |
| 06/23/2011 | US20110150889 Haemophilus influenzae type iv pili |
| 06/23/2011 | US20110150886 Anti-areg/hb-egf antibodies and treatment |
| 06/23/2011 | US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150882 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 06/23/2011 | US20110150880 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150866 Compositions and Methods for Increasing Bone Mineralization |
| 06/23/2011 | US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | US20110150862 Inhibitors of stim1 for the treatment of cardiovascular disorders |
| 06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 06/23/2011 | US20110150859 method for selecting responders to blockade of integrin receptors |
| 06/23/2011 | US20110150856 Compositions and methods for treatment of vitiligo |
| 06/23/2011 | US20110150854 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 06/23/2011 | US20110150849 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/23/2011 | US20110150840 Detection and Treatment of Glyco-Enzyme-Related Disease |
| 06/23/2011 | US20110150836 Methods of treating hbv and hcv infection |
| 06/23/2011 | US20110150835 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | US20110150833 Benzopyrans and analogs as rho kinase inhibitors |
| 06/23/2011 | US20110150831 Novel naphthyridine derivatives and the use thereof as kinase inhibitors |
| 06/23/2011 | US20110150829 Antiviral nucleosides |
| 06/23/2011 | US20110150828 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof |
| 06/23/2011 | US20110150827 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| 06/23/2011 | US20110150825 Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
| 06/23/2011 | US20110150822 Pheromone compositions and methods of use |
| 06/23/2011 | US20110150821 Methods and crosslinked polymer compositions for cartilage repair |
| 06/23/2011 | US20110150790 Glucosyltransferase inhibitor containing epigallocatechin gallate polymer as active ingredient |
| 06/23/2011 | US20110150784 Combination therapy for copd |
| 06/23/2011 | US20110150778 Assembly of Gas-Filled Microvesicle With Active Component For Contrast Imaging |
| 06/23/2011 | US20110150775 Genomic approaches to fetal treatment and diagnosis |
| 06/23/2011 | US20110150769 Identification and use of compounds for treating persistent pain |
| 06/23/2011 | US20110150767 Alpha-substituted and alpha-unsubstituted aromatic amino acid derivatives and compositions thereof for use to treat, diagnose, or monitor a medical condition |
| 06/23/2011 | US20110150766 Transdermal patch with fatal overdose protection |
| 06/23/2011 | US20110150763 Triazine derivatives and their therapeutical applications |
| 06/23/2011 | US20110150757 Compounds for inhibiting ksp kinesin activity |
| 06/23/2011 | US20110146693 Intrauterine delivery system for contraception |
| 06/23/2011 | US20110146678 Process for improving crystallinity |
| 06/23/2011 | US20110145970 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
| 06/23/2011 | CA2785064A1 Prostate specific membrane antigen inhibitors |
| 06/23/2011 | CA2784933A1 Processes for the purification of lubiprostone |
| 06/23/2011 | CA2784836A1 Improved method of administering .beta.-hydroxy-.beta.-methylbutyrate (hmb) |
| 06/23/2011 | CA2784830A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 06/23/2011 | CA2784827A1 Composition of dexibuprofen transdermal hydrogel |
| 06/23/2011 | CA2784788A1 Methods and compositions for treating peripheral vascular disease |
| 06/23/2011 | CA2784785A1 Methods and compositions for treating inflammation of skin |
| 06/23/2011 | CA2784753A1 Substituted aminothiazolone indazoles as estrogen related receptor-.alpha. modulators |
| 06/23/2011 | CA2784748A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| 06/23/2011 | CA2784712A1 Percutaneous absorption preparation comprising anti-dementia drug |
| 06/23/2011 | CA2784710A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
| 06/23/2011 | CA2784689A1 Local delivery of drugs from self assembled coatings |
| 06/23/2011 | CA2784646A1 Hcv combination therapy |
| 06/23/2011 | CA2784596A1 Beta-cell replication promoting compounds and methods of their use |
| 06/23/2011 | CA2784566A1 Heterocyclic compounds and their uses |
| 06/23/2011 | CA2784529A1 Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
| 06/23/2011 | CA2784500A1 Anti-thrombosis aptamers and method for stabilizing the structure thereof |
| 06/23/2011 | CA2784308A1 Preventing or ameliorating agent for pigmentation |
| 06/23/2011 | CA2784297A1 Compositions and methods related to mirna in diabetic conditions |
| 06/23/2011 | CA2784252A1 Dicer substrate agents and methods for the specific inhibition of gene expression |
| 06/23/2011 | CA2784215A1 Therapeutic combinations of theobromine and an antihistamine |
| 06/23/2011 | CA2784214A1 Combination of theobromine with a decongestant and its use for the treatment of cough |
| 06/23/2011 | CA2784207A1 Antibiotic microparticles for inhalation |
| 06/23/2011 | CA2784145A1 Methods and compositions related to clot-binding compounds |
| 06/23/2011 | CA2784141A1 Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles |
| 06/23/2011 | CA2784133A1 Felbinac-containing transdermally absorbable preparation |
| 06/23/2011 | CA2784122A1 Antiparasitic dihydroazole compounds and compositions comprising same |
| 06/23/2011 | CA2784119A1 Compounds for the treatment of neurologic disorders |
| 06/23/2011 | CA2784087A1 Mannose derivatives as antagonists of bacterial adhesion |
| 06/23/2011 | CA2784075A1 Inhibitors of sphingosine kinase |
| 06/23/2011 | CA2784067A1 Thiazole derivatives for the treatment of diseases such as cancer |
| 06/23/2011 | CA2784015A1 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail |
| 06/23/2011 | CA2784013A1 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4, 3-c] isoquinoline derivatives |
| 06/23/2011 | CA2784010A1 Novel solvates of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate |
| 06/23/2011 | CA2783964A1 Piroxicam-containing transdermally absorbable preparation |
| 06/23/2011 | CA2783892A1 Modulator |
| 06/23/2011 | CA2783891A1 Antifungal composition intended to be applied to a perforated nail |
| 06/23/2011 | CA2783801A1 Prodrugs of inhibitors of plasma kallikrein |
| 06/23/2011 | CA2783728A1 Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors |
| 06/23/2011 | CA2783726A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors |
| 06/23/2011 | CA2783696A1 Use of compounds in the treatment or prevention of skin disorders |
| 06/23/2011 | CA2783569A1 Transdermally absorbable preparation containing basic anti-inflammatory analgesic |
| 06/23/2011 | CA2783556A1 Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases |
| 06/23/2011 | CA2783366A1 Uniform field magnetization and targeting of therapeutic formulations |
| 06/23/2011 | CA2782967A1 Traditional chinese drug comprising danshen extracts and sanqi extracts and use thereof |
| 06/23/2011 | CA2782950A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
| 06/23/2011 | CA2782947A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
| 06/23/2011 | CA2782889A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | CA2782872A1 Compositions and methods for ophthalmic delivery of nasal decongestants |
| 06/23/2011 | CA2782720A1 Pyrrolo[2,3-d]pyrimidine compounds |